Form 4 for OGN Organon & Co.
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-04 · accession 0001821825-24-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | 2024-05-04 | OGN | Ali Kevin | CEO, Dir | M - OptEx | $0.00 | +22.2K | 147.5K | +18% | $0 |
| D | 2024-05-07 | 2024-05-04 | OGN | Ali Kevin | CEO, Dir | F - Tax | $19.61 | -12.3K | 135.2K | -8% | -$240.3K |
| D | 2024-05-07 | 2024-05-04 | OGN | Ali Kevin | CEO, Dir | M - OptEx | $0.00 | -22.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-04 | M | A | 22,161 | $0.00 | 147,504 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-04 | F | D | 12,256 | $19.61 | 135,248 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-05-04 | M | D | 22,161 | $0.00 | 0 | D | — · — to — | 22,161 Common Stock | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. (F2) On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested. |